Cargando…

Risk Factors and Clinical Impact of Carbapenem-Resistant Enterobacterales Coinfections Among Hospitalized Patients with Clostridioides difficile Infection

INTRODUCTION: The risk factors and clinical impact of carbapenem-resistant Enterobacterales (CRE) coinfection among hospitalized patients with Clostridioides difficile infection (CDI) were analyzed in this study. MATERIALS AND METHODS: A clinical study was performed at the medical wards of Tainan Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ching-Chi, Chiu, Chun-Wei, Lee, Jen-Chieh, Tsai, Pei-Jane, Ko, Wen-Chien, Hung, Yuan-Pin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635385/ https://www.ncbi.nlm.nih.gov/pubmed/36337933 http://dx.doi.org/10.2147/IDR.S386309

Ejemplares similares

Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections
por: Lee, Ching-Chi, et al.
Publicado: (2022)

Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2021)

Neutrophil Ratio of White Blood Cells as a Prognostic Predictor of Clostridioides difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2022)

Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus
por: LEE, Jen-Chieh, et al.
Publicado: (2021)

Association of Single Nucleotide Polymorphisms in Nucleotide-Binding Domain Leucine-Rich Repeat Protein 1 with Clostridioides difficile Colonization or Infection
por: Tsai, Bo-Yang, et al.
Publicado: (2023)

Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
por: Chiu, Chun-Wei, et al.
Publicado: (2021)

The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant Enterobacterales
por: Hung, Yuan-Pin, et al.
Publicado: (2021)

Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice
por: Tsai, Bo-Yang, et al.
Publicado: (2022)

Peroxisome proliferator-activated receptor-γ as the gatekeeper of tight junction in Clostridioides difficile infection
por: Lai, Yi-Hsin, et al.
Publicado: (2022)

COVID-19 and coinfection with Clostridioides ( Clostridium ) difficile in an infant with gastrointestinal manifestation
por: Oba, Jane, et al.
Publicado: (2020)

The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients
por: Lai, Yi-Hsin, et al.
Publicado: (2021)

Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease Severity
por: Lee, Jen-Chieh, et al.
Publicado: (2016)

Corrigendum: The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients
por: Lai, Yi-Hsin, et al.
Publicado: (2021)

Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
por: Sehgal, Kanika, et al.
Publicado: (2021)

Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection
por: Hung, Yuan-Pin, et al.
Publicado: (2015)

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?
por: Hung, Yuan-Pin, et al.
Publicado: (2022)

2461. Carbapenem-resistant Enterobacterales reported to the National Healthcare Safety Network Multidrug-Resistant Organism & Clostridioides difficile Infection Module, January 2018 to July 2022
por: Cincotta, Samuel E, et al.
Publicado: (2023)

Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics
por: Hung, Yuan-Pin, et al.
Publicado: (2021)

Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
por: Chen, Hsin-Yu, et al.
Publicado: (2021)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan
por: Hung, Yuan-Pin, et al.
Publicado: (2016)

Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan
por: Hung, Yuan-Pin, et al.
Publicado: (2018)

Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic Exposure
por: Hung, Yuan-Pin, et al.
Publicado: (2013)

Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
por: Lan, Kai-Yen, et al.
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Novel metal peroxide nanoboxes restrain Clostridioides difficile infection beyond the bactericidal and sporicidal activity
por: Yang, Li‐Xing, et al.
Publicado: (2023)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon
por: Fadlallah, Mahdi, et al.
Publicado: (2023)

COVID-19 and Clostridioides difficile Coinfection Outcomes among Hospitalized Patients in the United States: An Insight from National Inpatient Database
por: Awan, Rehmat Ullah, et al.
Publicado: (2023)

A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox
por: Hung, Yuan-Pin, et al.
Publicado: (2022)

588. Ceftolozane/Tazobactam Susceptibility of Carbapenem-Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacterales Isolates in a Tertiary Hospital in Korea
por: Kim, Kye-Hyung, et al.
Publicado: (2023)

Impact of Toxigenic Clostridium difficile Colonization and Infection among Hospitalized Adults at a District Hospital in Southern Taiwan
por: Hung, Yuan-Pin, et al.
Publicado: (2012)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Association between duration of antipseudomonal beta-lactam therapy and Clostridioides difficile infections in monomicrobial Enterobacterales bloodstream infections at an academic medical center
por: Hawkins, Audry M., et al.
Publicado: (2022)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales
por: Takei, Kentarou, et al.
Publicado: (2023)

Clostridioides difficile Is Not Difficult to Predict in Hospital Settings
por: Alexander, Kinta, et al.
Publicado: (2021)

Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic
por: Chiu, Cheng-Hsun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m2hjif5eac0lfogevao6cced88